Analysis of Profitability Ratios
Profitability ratios measure the company ability to generate profitable sales from its resources (assets).
Profitability Ratios (Summary)
CVS Health Corp., profitability ratios
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | CVS Health Corp. gross profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | CVS Health Corp. operating profit margin ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | CVS Health Corp. net profit margin ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | CVS Health Corp. ROE improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024 not reaching 2022 level. |
| ROA | A profitability ratio calculated as net income divided by total assets. | CVS Health Corp. ROA improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024 not reaching 2022 level. |
Gross Profit Margin
CVS Health Corp., gross profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Gross profit | 49,248) | 53,278) | 53,456) | 50,849) | 48,248) | |
| Revenues from customers | 370,656) | 356,623) | 321,629) | 290,912) | 267,908) | |
| Profitability Ratio | ||||||
| Gross profit margin1 | 13.29% | 14.94% | 16.62% | 17.48% | 18.01% | |
| Benchmarks | ||||||
| Gross Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 50.93% | 50.28% | 51.54% | 52.21% | 50.49% | |
| Cigna Group | 10.15% | 12.37% | 12.44% | 12.41% | 14.43% | |
| Elevance Health Inc. | 15.92% | 16.79% | 16.79% | 17.09% | 19.71% | |
| Intuitive Surgical Inc. | 67.46% | 66.39% | 67.44% | 69.32% | 65.65% | |
| Medtronic PLC | 65.34% | 65.67% | 67.98% | 65.19% | 67.41% | |
| UnitedHealth Group Inc. | 21.31% | 23.64% | 24.09% | 23.60% | 25.62% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Gross profit margin = 100 × Gross profit ÷ Revenues from customers
= 100 × 49,248 ÷ 370,656 = 13.29%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Gross profit margin | Gross profit margin indicates the percentage of revenue available to cover operating and other expenditures. | CVS Health Corp. gross profit margin ratio deteriorated from 2022 to 2023 and from 2023 to 2024. |
Operating Profit Margin
CVS Health Corp., operating profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Operating income | 8,516) | 13,743) | 7,746) | 13,193) | 13,911) | |
| Revenues from customers | 370,656) | 356,623) | 321,629) | 290,912) | 267,908) | |
| Profitability Ratio | ||||||
| Operating profit margin1 | 2.30% | 3.85% | 2.41% | 4.54% | 5.19% | |
| Benchmarks | ||||||
| Operating Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 16.27% | 16.15% | 19.16% | 19.56% | 15.48% | |
| Cigna Group | 3.83% | 4.40% | 4.69% | 4.60% | 5.12% | |
| Elevance Health Inc. | 4.16% | 4.47% | 4.94% | 5.15% | 4.97% | |
| Intuitive Surgical Inc. | 28.12% | 24.80% | 25.35% | 31.89% | 24.09% | |
| Medtronic PLC | 15.89% | 17.56% | 18.15% | 14.89% | 16.57% | |
| UnitedHealth Group Inc. | 8.17% | 8.80% | 8.83% | 8.40% | 8.76% | |
| Operating Profit Margin, Sector | ||||||
| Health Care Equipment & Services | — | 6.51% | 6.41% | 6.93% | 7.08% | |
| Operating Profit Margin, Industry | ||||||
| Health Care | — | 9.87% | 13.87% | 13.77% | 10.81% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Operating profit margin = 100 × Operating income ÷ Revenues from customers
= 100 × 8,516 ÷ 370,656 = 2.30%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Operating profit margin | A profitability ratio calculated as operating income divided by revenue. | CVS Health Corp. operating profit margin ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Net Profit Margin
CVS Health Corp., net profit margin calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income attributable to CVS Health | 4,614) | 8,344) | 4,149) | 7,910) | 7,179) | |
| Revenues from customers | 370,656) | 356,623) | 321,629) | 290,912) | 267,908) | |
| Profitability Ratio | ||||||
| Net profit margin1 | 1.24% | 2.34% | 1.29% | 2.72% | 2.68% | |
| Benchmarks | ||||||
| Net Profit Margin, Competitors2 | ||||||
| Abbott Laboratories | 31.95% | 14.27% | 15.88% | 16.42% | 12.99% | |
| Cigna Group | 1.40% | 2.66% | 3.72% | 3.11% | 5.31% | |
| Elevance Health Inc. | 3.41% | 3.52% | 3.87% | 4.46% | 3.78% | |
| Intuitive Surgical Inc. | 27.81% | 25.24% | 21.25% | 29.85% | 24.33% | |
| Medtronic PLC | 11.36% | 12.03% | 15.90% | 11.97% | 16.56% | |
| UnitedHealth Group Inc. | 3.65% | 6.09% | 6.25% | 6.06% | 6.03% | |
| Net Profit Margin, Sector | ||||||
| Health Care Equipment & Services | — | 4.56% | 4.74% | 5.08% | 5.27% | |
| Net Profit Margin, Industry | ||||||
| Health Care | — | 8.47% | 10.73% | 11.32% | 8.06% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Net profit margin = 100 × Net income attributable to CVS Health ÷ Revenues from customers
= 100 × 4,614 ÷ 370,656 = 1.24%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| Net profit margin | An indicator of profitability, calculated as net income divided by revenue. | CVS Health Corp. net profit margin ratio improved from 2022 to 2023 but then deteriorated significantly from 2023 to 2024. |
Return on Equity (ROE)
CVS Health Corp., ROE calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income attributable to CVS Health | 4,614) | 8,344) | 4,149) | 7,910) | 7,179) | |
| Total CVS Health shareholders’ equity | 75,560) | 76,461) | 71,015) | 75,075) | 69,389) | |
| Profitability Ratio | ||||||
| ROE1 | 6.11% | 10.91% | 5.84% | 10.54% | 10.35% | |
| Benchmarks | ||||||
| ROE, Competitors2 | ||||||
| Abbott Laboratories | 28.12% | 14.83% | 18.90% | 19.75% | 13.71% | |
| Cigna Group | 8.37% | 11.17% | 14.86% | 11.39% | 16.81% | |
| Elevance Health Inc. | 14.47% | 15.23% | 16.59% | 16.93% | 13.77% | |
| Intuitive Surgical Inc. | 14.13% | 13.51% | 11.98% | 14.32% | 10.90% | |
| Medtronic PLC | 7.32% | 7.30% | 9.59% | 7.01% | 9.44% | |
| UnitedHealth Group Inc. | 15.55% | 25.22% | 25.87% | 24.09% | 23.52% | |
| ROE, Sector | ||||||
| Health Care Equipment & Services | — | 15.01% | 15.22% | 14.90% | 14.75% | |
| ROE, Industry | ||||||
| Health Care | — | 18.07% | 22.47% | 22.98% | 16.02% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
ROE = 100 × Net income attributable to CVS Health ÷ Total CVS Health shareholders’ equity
= 100 × 4,614 ÷ 75,560 = 6.11%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROE | A profitability ratio calculated as net income divided by shareholders’ equity. | CVS Health Corp. ROE improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024 not reaching 2022 level. |
Return on Assets (ROA)
CVS Health Corp., ROA calculation, comparison to benchmarks
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Selected Financial Data (US$ in millions) | ||||||
| Net income attributable to CVS Health | 4,614) | 8,344) | 4,149) | 7,910) | 7,179) | |
| Total assets | 253,215) | 249,728) | 228,275) | 232,999) | 230,715) | |
| Profitability Ratio | ||||||
| ROA1 | 1.82% | 3.34% | 1.82% | 3.39% | 3.11% | |
| Benchmarks | ||||||
| ROA, Competitors2 | ||||||
| Abbott Laboratories | 16.46% | 7.82% | 9.31% | 9.40% | 6.20% | |
| Cigna Group | 2.20% | 3.38% | 4.63% | 3.46% | 5.44% | |
| Elevance Health Inc. | 5.12% | 5.50% | 5.86% | 6.26% | 5.28% | |
| Intuitive Surgical Inc. | 12.39% | 11.64% | 10.19% | 12.58% | 9.50% | |
| Medtronic PLC | 4.09% | 4.13% | 5.54% | 3.87% | 5.28% | |
| UnitedHealth Group Inc. | 4.83% | 8.18% | 8.19% | 8.15% | 7.81% | |
| ROA, Sector | ||||||
| Health Care Equipment & Services | — | 5.51% | 5.59% | 5.58% | 5.44% | |
| ROA, Industry | ||||||
| Health Care | — | 6.47% | 8.43% | 8.29% | 5.45% | |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
ROA = 100 × Net income attributable to CVS Health ÷ Total assets
= 100 × 4,614 ÷ 253,215 = 1.82%
2 Click competitor name to see calculations.
| Profitability ratio | Description | The company |
|---|---|---|
| ROA | A profitability ratio calculated as net income divided by total assets. | CVS Health Corp. ROA improved from 2022 to 2023 but then slightly deteriorated from 2023 to 2024 not reaching 2022 level. |